Laboratory-Developed Tests - Medical devices 2017

MessageThis Webinar is over
Date Aug 10, 2017
Time 10:00 AM
Cost 150.00
This presentation will review the legal definition of medical device, and how

it is applied by FDA to in vitro diagnostic tests. It will review the history of

FDA interest in LDTs, and will describe the current situation with respect to

Laboratory-developed tests.

Why should you Attend:
This 1 hour session will explore the reasons FDA has for claiming such

jurisdiction, and the objections to FDAs' position articulated by the clinical

laboratory community, and others.

Areas Covered in the Session:
"Enforcement Discretion" and how it has been applied to LDT regulation
Extent of CLIA '88 authority over LDT performance
Role of US Congress in answering the question of FDA authority
International (EU) approach to LDTs

Who Will Benefit:
QA Specialist
Complaint Coordinator
Regulatory Specialist
QA Manager
QA Trainer
All above in Medical Device companies

Speaker Profile:
Anna Longwell is currently principal attorney of the Palo Alto Law firm,

Longwell and Associates, which specializes in Food and Drug law. The firm

has expertise in US FDA expectations, regulation and law, affecting the

development and ultimate marketing of new medical products, drugs,

devices and biologics. They have served the regulatory needs of large (>$2

billion/year) divisions of Fortune 500 companies, and small (4 person)

biotech start-ups.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list